...
首页> 外文期刊>Journal of the American College of Cardiology >Direct coronary stenting without predilation.
【24h】

Direct coronary stenting without predilation.

机译:直接冠状动脉支架置入术无需扩张。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: Coronary stenting is the primary therapeutic option for percutaneous treatment of many coronary lesions, after the risk of subacute stent thrombosis and bleeding complications has been reduced by improved antithrombotic regimens and high pressure stent expansion. BACKGROUND: Direct stent implantation (without predilation) has been considered a promising new technique that may reduce the procedure time, radiation exposure time and cost. METHODS: After having reviewed all cases of stent implantation from February to June 1998 (n = 585), 185 (32%) of these patients were retrospectively considered candidates for direct stent implantation without predilation, according to prespecified criteria (i.e., absence of severe coronary calcifications and/or tortuosity of the lesion or the segment proximal to the lesion). By operator preference, direct coronary stent implantation was actually attempted in 123 (21%) of the 585 patients (100 men, 60 +/- 10 years old) on 123 lesions. The impact of direct stenting in terms of cost, procedure time, radiation exposure time and amount of contrast dye used was assessed by comparing the two groups of patients who underwent single-vessel stenting without (n = 69) and with (n = 46) predilation. RESULTS: Direct stenting was successful in 118 patients (96%). No acute or subacute complications occurred in these patients. Procedure time, radiation exposure time and cost were significantly lower in the group of patients who had single-vessel direct versus conventional stenting (45 +/- 31 vs. 64 +/- 46 min, 12 +/- 9 vs. 16 +/- 10 min and 1,305 +/- 363 vs. 2,210 +/- 803 Euro, respectively; p < 0.05 for all). CONCLUSIONS: Direct stenting without predilation in selected lesions seems to be a safe and successful procedure that provides a way to contain cost and to shorten radiation exposure time.
机译:目的:通过改进抗血栓治疗方案和高压支架扩张降低亚急性支架血栓形成和出血并发症的风险后,冠状动脉支架置入术是经皮治疗许多冠状动脉病变的主要治疗选择。背景:直接支架植入(无扩张术)被认为是一种有前途的新技术,可以减少手术时间,减少辐射暴露时间并降低成本。方法:在回顾了1998年2月至1998年6月的所有支架植入病例(n = 585)后,根据预先确定的标准(即,没有严重的并发症),其中185例(32%)被回顾性考虑为无扩张的直接支架植入的候选人。病变或病变近端的冠状动脉钙化和/或曲折)。根据操作者的喜好,实际上在585例(100名男性,60 +/- 10岁)的123例患者中,有123例(21%)尝试了直接冠状动脉支架植入术。通过比较两组在不使用(n = 69)和使用(n = 46)的情况下进行单支血管支架置入术的患者,评估了直接置入术对费用,手术时间,放射线照射时间和使用的对比染料量的影响。掠夺。结果:118例患者中直接支架置入术成功(96%)。这些患者没有发生急性或亚急性并发症。与传统支架置入术相比,单支直接血管置入术的患者的手术时间,放射线照射时间和成本显着降低(45 +/- 31 vs. 64 +/- 46 min,12 +/- 9 vs. 16 + / -10分钟和1,305 +/- 363对,分别为2,210 +/- 803欧元; p均<0.05)。结论:在没有病变的情况下直接进行支架置入术似乎是一种安全而成功的方法,它为控制成本和缩短辐射暴露时间提供了一种方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号